MGX
Metagenomi, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$50.82M
P/E Ratio
—
EPS
$-2.29
Beta
0.65
52W High
$3.95
52W Low
$1.24
50-Day MA
$1.40
200-Day MA
$1.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Metagenomi, Inc. Common Stock
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emeryville, California.
Fundamentals
| Revenue (TTM) | $22.33M |
| Gross Profit (TTM) | $-72.10M |
| EBITDA | $-87.55M |
| Operating Margin | -1970.00% |
| Return on Equity | -49.00% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $0.60 |
| Book Value | $3.66 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 2.28 |
| EV/Revenue | 0.712 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -69.80% |
| Shares Outstanding | $37.65M |
| Float | $27.35M |
| % Insiders | 19.25% |
| % Institutions | 19.32% |
Historical Volatility
HV 10-Day
44.02%
HV 20-Day
41.02%
HV 30-Day
41.50%
HV 60-Day
55.73%
HV Rank
4.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026